Metrics as of 10/15/2026, 10:13 PM (Berlin time), refresh in progress.
Cocrystal Pharma Stock
Cocrystal Pharma, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- James E. Sapirstein
- Employees
- 10
- Market cap
- $20 M
- IPO
- 22/02/2012
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV),…
Cocrystal Pharma stock: price history
1D
-1.0%
1W
-4.7%
1M
-10.5%
6M
-32.5%
YTD
+4.2%
1Y
-4.7%
2Y
-53.6%
5Y
-91.0%
10Y
-99.4%
Next earnings date
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~28% weaker price swings than usual
Ask the agents about Cocrystal Pharma
Analyst assessment of Cocrystal Pharma
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 20/06/2025
Cocrystal Pharma stock metrics
P/E
-1.29
P/B
13.6
EV/EBITDA
-1.92
RETURN ON EQUITY
-303.1%
NET MARGIN
-3,013.3%
DEBT/EQUITY
1.28
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
61.8%
FLOAT SHARES
11,908,510
AVG. DAILY VOLUME (30D)
47,102
Insider transactions (SEC)
FROST PHILLIP MD ET AL
FROST PHILLIP MD ET AL
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Cocrystal Pharma stock
What does Cocrystal Pharma do?
Cocrystal Pharma, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is James E. Sapirstein, the company employs around 10 people.
The IPO was on 22/02/2012; the stock trades on NASDAQ under the ticker COCP.
What do analysts say about Cocrystal Pharma stock?
1 analysts rate the stock, the consensus is Buy (as of 20/06/2025).
This is an external assessment, not a statement by Market Jury.
When does Cocrystal Pharma report next?
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly -28% stronger than usual.
Does Cocrystal Pharma pay a dividend?
No, Cocrystal Pharma currently does not pay a dividend.
Which stocks are comparable to Cocrystal Pharma?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Cocrystal Pharma stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cocrystal Pharma against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.